Statements (17)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
vaccine
|
| gptkbp:composition |
saponin-based adjuvant
|
| gptkbp:contains |
Quillaja saponaria extract
|
| gptkbp:developedBy |
gptkb:Novavax
|
| gptkbp:firstClinicalUse |
2010s
|
| gptkbp:function |
enhances immune response
|
| https://www.w3.org/2000/01/rdf-schema#label |
Matrix-M
|
| gptkbp:mechanismOfAction |
stimulates antigen-presenting cells
|
| gptkbp:regulates |
approved in some countries
|
| gptkbp:relatedTo |
NVX-CoV2373 COVID-19 vaccine
|
| gptkbp:routeOfAdministration |
intramuscular
|
| gptkbp:usedIn |
gptkb:NVX-CoV2373
influenza vaccines malaria vaccines |
| gptkbp:bfsParent |
gptkb:Covovax
gptkb:Novavax_COVID-19_vaccine |
| gptkbp:bfsLayer |
5
|